Dr. Toms is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
593 Eddy St.
M.C. 14-05
Providence, RI 02903Phone+1 401-793-9175Fax+1 401-444-2788
Clinical Expertise
- Neurosurgical oncology, Gliomas, Radiosurgery, Meningiomas, Glioblastoma
Education & Training
- Cleveland Clinic FoundationResidency, Neurological Surgery, 1992 - 1997
- The Johns Hopkins University School of Public HealthMPH, 1991 - 1992
- Cleveland Clinic FoundationInternship, Transitional Year, 1989 - 1990
- The Warren Alpert Medical School of Brown UniversityClass of 1989
Certifications & Licensure
- OR State Medical License 2001 - Present
- MA State Medical License 2023 - 2026
- PA State Medical License 2007 - 2024
- RI State Medical License 2016 - 2024
- OH State Medical License 1990 - 2007
- TN State Medical License 1998 - 2006
- TX State Medical License 1997 - 2000
- American Board of Neurological Surgery Neurological Surgery
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FACS) American College of Surgeons
- Fellow (FAANS) American Association of Neurological Surgeons
Clinical Trials
- Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Start of enrollment: 2006 Dec 01
- Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Start of enrollment: 2009 Jun 01
Publications & Presentations
PubMed
- 12 citationsThe National Inpatient Sample: A Primer for Neurosurgical Big Data Research and Systematic Review.Oliver Y Tang, Alisa Pugacheva, Ankush I Bajaj, Krissia M Rivera Perla, Robert J Weil
World Neurosurgery. 2022-06-01 - 1438 citationsEffect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical TrialRoger Stupp, Sophie Taillibert, Andrew A. Kanner, William L. Read, David M. Steinberg
JAMA. 2017-12-19 - 195 citationsFirst results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.Linda M Liau, Keyoumars Ashkan, David D Tran, Jian L Campian, John E Trusheim
Journal of Translational Medicine. 2018-05-29
Journal Articles
- Regulation of Human Glioma Cell Migration, Tumor Growth, and Stemness Gene Expression Using a Lck Targeted InhibitorSteven Toms, MD, Nature
Authored Content
- Case Report: A Comparative Report on Intracranial Tumor-to-Tumor Metastasis and Collision TumorsApril 2018
Press Mentions
- Researchers Announce Major Breakthrough in Brain Cancer Vaccine Trial – WPRI.comJanuary 7th, 2023
- Researchers Announce Breakthrough in Brain Cancer Vaccine TrialJanuary 7th, 2023
- Brown-Lifespan Researchers Advance New Vaccine to Treat Brain CancerJanuary 6th, 2023
- Join now to see all
Professional Memberships
- Member
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: